HCPLive
The 2012 ACR/ARHP Annual Meeting will present the latest evidence-based research, news, information, and educational sessions designed to "enhance practice performance and improve the quality of care in those with or at risk for arthritis and rheumatic and musculoskeletal diseases."
ACR/ARHP 2012 Annual Meeting

ACR/ARHP 2012 Annual Meeting | ACR/ARHP 2012

Conference Coverages

Excess Weight Linked to Increased Risk of Developing Rheumatoid Arthritis
Excess Weight Linked to Increased Risk of Developing Rheumatoid Arthritis
Overweight women face a higher risk of rheumatoid arthritis than their normal-weight peers, according to a study presented at the annual scientific meeting of the American College of Rheumatology in Washington, DC.
Aggressive Anti-fraud Measures Put Rheumatologists under the Spotlight
Claims-based analysis using powerful algorithms, predictive sampling by aggressive ZPICs, a focus on disguised kickbacks, prepayment reviews that effectively freeze billing, and other anti-fraud measures add up to a challenging regulatory environment for rheumatologists.
With Chronic Low Back Pain Patients, Focus on Preventing Future Episodes
Although many patients suffering with low back pain are initially focused on pain relief, convincing them to shift their focus to prevention and functional improvement can lead to better clinical outcomes and greater patient satisfaction.
ACR: Depression Linked to Increased Mortality in RA
Depression and increased depressive symptoms correlate with increased mortality among patients with rheumatoid arthritis, particularly men, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 10 to 14 in Washington, D.C.
Pegloticase Effective in Treating the Most Severe Forms of Gout
Forty percent of patients treated with the uricase drug pegloticase saw complete resolution of one or more gouty tophi within 25 weeks.
Study Shows Methotrexate and Prednisone Combination Therapy Achieves Remission for Most RA Patients
Results presented at the American College of Rheumatology/Association of Rheumatology Professionals 2012 annual meeting show that adalimumab and methotrexate are more effective than DMARDs and prednisone in achieving remission in patients with early rheumatoid arthritis or undifferentiated arthritis patients.
Assessing and Diagnosing Complex Regional Pain Syndrome
Patients with Complex Regional Pain Syndrome (CRPS) may be afraid to volunteer information that helps clinicians accurately diagnose them.

Most Popular

$vacMongoViewPlus$ $vAR$